CTXR
Citius Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.60
+2.06%Next report
Analyst consensus
- Next report date
- Dec 22, 2026
- EPS estimate
- -$0.41
- Revenue estimate
- $2.9M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.34
- EPS estimate
- -$0.36
- Revenue actual
- $1.5M
- Revenue estimate
- $5.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -137.4%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.36 | -$0.34 | Beat 5.56% | $1.5M |
| May 15, 2026 | -$0.28 | -$0.95 | Miss -238.38% | $1.7M |
| Feb 13, 2026 | — | -$0.44 | — | $3.9M |
| Dec 25, 2025 | -$0.24 | -$0.44 | Miss -83.55% | — |
| Aug 12, 2025 | -$0.24 | -$0.80 | Miss -233.33% | — |
| May 14, 2025 | -$1.08 | -$1.27 | Miss -17.59% | — |
| Feb 14, 2025 | -$1.25 | -$1.30 | Miss -4.00% | — |
| May 14, 2024 | -$1.50 | -$1.25 | Beat 16.67% | — |
| Feb 14, 2024 | $3.25 | -$1.50 | Miss -146.15% | — |
| Aug 14, 2023 | -$1.50 | -$1.50 | In line | — |
| May 12, 2023 | -$1.00 | -$1.75 | Miss -75.00% | — |
| Feb 10, 2023 | — | -$1.00 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 22, 2026